.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Fish and Richardson
Teva
US Army
Express Scripts
Argus Health
Cantor Fitzgerald
Harvard Business School
Accenture
Chinese Patent Office
Mallinckrodt

Generated: June 26, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 064052

« Back to Dashboard
NDA 064052 describes TOBRAMYCIN, which is a drug marketed by Amneal Pharms, Akorn Inc, Fera Pharms, Bausch And Lomb, Lupin Atlantis, Alcon Pharms Ltd, Apotex Inc, Teva Pharms Usa, Mylan Labs Ltd, Hospira, West-ward Pharms Int, X Gen Pharms, Igi Labs Inc, Apothecon, Fresenius Kabi Usa, Watson Labs Inc, Claris, Akorn, and Xellia Pharms Aps, and is included in thirty-six NDAs. It is available from fourteen suppliers. Additional details are available on the TOBRAMYCIN profile page.

The generic ingredient in TOBRAMYCIN is tobramycin sulfate. There are eighteen drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the tobramycin sulfate profile page.

Summary for NDA: 064052

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details

Pharmacology for NDA: 064052

Ingredient-typeAminoglycosides

Suppliers and Packaging for NDA: 064052

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TOBRAMYCIN
tobramycin
SOLUTION/DROPS;OPHTHALMIC 064052 ANDA Major Pharmaceuticals 0904-2970 0904-2970-05 1 BOTTLE, DROPPER in 1 CARTON (0904-2970-05) > 5 mL in 1 BOTTLE, DROPPER
TOBRAMYCIN
tobramycin
SOLUTION/DROPS;OPHTHALMIC 064052 ANDA MWI 13985-743 13985-743-05 1 BOTTLE, DROPPER in 1 CARTON (13985-743-05) > 5 mL in 1 BOTTLE, DROPPER

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION/DROPS;OPHTHALMICStrength0.3%
Approval Date:Nov 29, 1993TE:ATRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Healthtrust
Accenture
Harvard Business School
Argus Health
Merck
Chubb
Mallinckrodt
Fuji
US Department of Justice
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot